Zyus Life Sciences closes CAD$50,000 unsecured debt financing at 15% interest
Reuters2026/09/11 22:04- Zyus closed an unsecured debt financing, issuing an unsecured promissory note for CAD 50,000 to an arm’s-length lender.
- Note carries 15% simple annual interest from issuance, payable at maturity on Dec. 10, 2026.
- Instrument is non-convertible. Prepayment is permitted at any time without penalty or premium.
- Proceeds earmarked for general working capital.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cantex Mine Development closes second tranche of private placement for $1.01 million proceeds
PVH CEO Stefan Larsson acquires USD 999,999 of common shares
The rebound of the yen may only be temporary, Morgan Stanley bets on arbitrage trades making a comeback, USD/JPY expected to rise to 163.
Morgan Stanley believes that the recent strengthening of the Japanese yen is mainly due to the unwinding of short-term arbitrage trades and market bets on Japanese capital repatriation, rather than any substantial improvement in fundamentals.

Edwards Lifesciences CVP, TAVR Daniel J. Lippis disposes of 619 common shares worth $54,168.69